No Empty Shelves: Diabetes Supplies,
There When Needed - a
partnership with PATH
Since 2014, Novo Nordisk and PATH have collaborated on the No Empty
Shelves partnership project. The aim has been to address the barriers
to access to affordable essential medicines and technologies (EMTs)
for diabetes in low- and middle-income countries (LMICs).?
- Strengthen the global evidence base on availability of
affordable essential medicines and technologies for diabetes in
- Raise awareness of major barriers to availability of
affordable diabetes EMTs.?
- Build a network of key
stakeholders committed to taking action to increase the availability
of affordable EMTs for diabetes and other NCDs.
The work of No Empty Shelves has been guided by a Technical Advisory
Committee, comprised of the global health and development experts.?
The findings of No Empty Shelves clearly confirm that technologies –
blood glucose monitoring (BGM) and syringes – and not insulin are the
least affordable amongst the EMTs surveyed. Availability is very low
in the public sectors, rural areas, and lower levels of care. The
causes are various - from procurement issues that can impact supply to
taxes and unregulated mark-ups that drive up costs.1
- A comprehensive and peer-reviewed list of 22 EMTs necessary to
diagnose and treat diabetes and its common comorbidities
global landscape report?“Diabetes Supplies: Are they
there when needed?”?published by PATH in 2015.?
comprehensive country assessments of the supply chain, availability
and affordability of said medicines and products in Kenya and
Senegal – manuscripts pending approval for publishing in
- A global?Call to Action?calling for
access, availability, and affordability of essential medicines and
technologies for noncommunicable diseases.??
- The groundwork
for establishing a cross-disciplinary coalition to increase access
to essential medicines and technologies for NCDs.?The result of this
groundwork is the global Coalition for Access to NCD Medicines and
Products, launched in September 2017 in New York, and of which Novo
Nordisk is a founding member.
See more about PATH and our corporate partnership?here
1. PATH. Diabetes Supplies: Are they there when needed?
Seattle: PATH; 2015